Aliakbar Shahsafaei has extensive experience in histology science, with a focus on immunohistochemistry. Aliakbar Shahsafaei, 'smost recent position was as a Senior Histology Scientist at Certis Oncology Solutions, Inc. Aliakbar Shahsafaei, joined the company in June 2020 and is currently in the role.
Prior to this, Aliakbar worked as a Research Scientist at Halozyme Therapeutics, Inc. from December 2017 to June 2020. During this time, they contributed to research projects in the field.
Before joining Halozyme Therapeutics, Inc., Aliakbar worked at UC San Diego Health as an Immunohistochemistry Specialist II in the Pathology Department. In this role from February 2017 to September 2017, they were responsible for IHC assay design, implementation, and troubleshooting, as well as processing and staining clinical specimens for pathologist review.
Aliakbar also gained significant experience at Brigham and Women's Hospital as a Research Associate and Immunohistochemistry Specialist II from July 1994 to February 2017. Aliakbar Shahsafaei, performed various immunohistochemistry techniques, trained team members, and worked on clinical cases.
Earlier in their career, Aliakbar worked as a Research Technologist at Shriner Burn Hospital from 1991 to 1993, and as a Research Technician at MEEI, Howe Laboratory of Ophthalmology from 1987 to 1991.
Aliakbar Shahsafaei holds a Master's Degree in Biotechnology and Biomedical Science from UMass Boston. Additionally, they have obtained certifications in HTL (ASCP) and QIHC (ASCP) from the American Society for Clinical Pathology (ASCP).
Sign up to view 0 direct reports
Get started